Becker's Hospital Review - Cardiology

NOVEMBER 25, 2024

Of those, 97 hospitals were recognized for delivering superior clinical outcomes in cardiac care for heart bypass surgery, coronary interventional procedures, heart attack treatment, heart failure treatment and heart valve surgery.

Hospital 105

Hospital Heart Attack Heart attacks Heart Valves 105

Cardiology Update

APRIL 25, 2024

RELIEVE-HF investigators evaluated the efficacy and safety of the V-wave interatrial shunt system in patients with heart failure. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. Atlanta, GA.

Heart Failure 98

Heart Failure Heart Transplant Transplant Research 98

Circulation: Heart Failure

MARCH 14, 2025

Circulation: Heart Failure, Ahead of Print. The genotype-phenotype interdependence causes unpredictable phenotypic penetrance that results in a variety of signs and symptoms and patient outcomes. About 3% to 4% of patients with African ancestry carry this genetic predisposition to develop signs and symptoms of hATTR-CA.

Genetic predisposition 71

Genetic predisposition Heart Failure Biomarkers Circulation 71

DAIC

SEPTEMBER 19, 2024

recently announced that Digitiva, a non-invasive digital health solution for heart failure management, has been listed with the U.S. a smartphone app designed for heart failure patients and built on the Welldoc, Inc. tim.hodson Thu, 09/19/2024 - 09:42 Sept. 18, 2024 – Astellas Pharma Inc.

Heart Failure 105

Heart Failure Technology Biomarkers Innovation 105

DAIC

FEBRUARY 26, 2024

milla1cf Mon, 02/26/2024 - 12:40 February 26, 2024 — More than 6 million Americans live with heart failure , and about half have an enlarged left ventricle, which causes stress on the heart and less blood pumped with each heartbeat. Patients may experience trouble breathing and fatigue, and at times require hospitalization.

Heart Failure 119

Heart Failure Open-Heart Surgery Hospital Outcomes 119

European Journal of Heart Failure

FEBRUARY 16, 2025

Baseline characteristics for the vericiguat global study in participants with chronic heart failure (VICTOR) trial. of participants had no prior hospitalization for heart failure. Conclusion The VICTOR trial enrolled the most optimally treated population in a phase III heart failure trial.

Heart Failure 40

Heart Failure Defibrillator Hospital Outcomes 40

DAIC

FEBRUARY 6, 2024

Matthew Segar co-authored a study in JACC Heart Failure led by his research and residency mentor, University of Texas Southwestern Medical Center's Dr. Ambarish Pandey , that utilized a machine learning-based-approach to identify, understand, and predict diuretic responsiveness in patients with acute decompensated heart failure (ADHF).

Heart Failure 111

Heart Failure Research Hospital Cardiovascular Disease 111

Frontiers in Cardiovascular Medicine

MARCH 7, 2024

Background Belt electrode skeletal muscle electrical stimulation (B-SES) is an emerging therapy anticipated to yield more favorable outcomes than conventional neuromuscular electrical stimulation (NMES), owing to its larger stimulation area. However, information on its efficacy and safety in patients with heart failure remains limited.

Heart Failure 124

Heart Failure Obesity Heart Transplant Transplant 124

DAIC

FEBRUARY 21, 2024

Getty Images milla1cf Wed, 02/21/2024 - 19:10 February 21, 2024 — Ochsner Children's Hospital , ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices.

Pediatrics 105

Pediatrics Hospital Heart Failure Transplant 105

DAIC

MAY 28, 2024

milla1cf Tue, 05/28/2024 - 07:00 May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024 , a scientific congress of the European Society of Cardiology (ESC).

Heart Failure 98

Heart Failure Quality of Life Research Blood Pressure 98

DAIC

FEBRUARY 21, 2024

Henry Ford Health's Center for Structural Heart Disease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heart failure patient on February 13, 2024 at Henry Ford Hospital in Detroit. She is only the third patient in the U.S. to receive the device.

Heart Failure 105

Heart Failure Open-Heart Surgery Tricuspid Heart Disease 105

European Journal of Heart Failure

NOVEMBER 29, 2023

ABSTRACT Aims Heart failure outcomes remain poor despite advances in therapy. The European Society of Cardiology Heart Failure III Registry (ESC HF III Registry) aims to characterize HF clinical features and outcomes and to assess implementation of guideline-recommended therapy in Europe and other ESC affiliated countries.

Heart Failure 75

Heart Failure Preserved Ejection Fraction Quality of Life Biomarkers 75

DAIC

JULY 12, 2024

Lead researcher Dr Pankaj Garg , of the University of East Anglia’s Norwich Medical School and a consultant cardiologist at the Norfolk and Norwich University Hospital, heads up a team of researchers who have pioneered innovative and revolutionary 4D MRI imaging technology.

Outcomes 122

Outcomes Hospital Research Innovation 122

Frontiers in Cardiovascular Medicine

MARCH 30, 2025

Demographic, clinical, and diagnostic data, as well as follow-up outcomes, were reviewed. Logistic and Cox regression models identified risk factors for in-hospital and long-term mortality.ResultsAmong the 212 patients, 79.72% (169/212) had HCM, 16.98% (36/212) had RCM, and 3.30% (7/212) had RP-HCM.

Risk Factors 52

Risk Factors Pediatrics Cardiomyopathy Pulmonary 52

DAIC

MAY 6, 2024

The primary outcome measure for the study is change in six-minute walk distance from Baseline to Week 12. Initially discovered and developed by Orion Corporation in Finland, intravenous levosimendan is approved in 60 countries outside the United States for use in hospitalized patients with acutely decompensated heart failure.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Heart Failure Pulmonary Hypertension 105

JAMA Cardiology

MAY 28, 2024

This cohort study examines the incidence of dialysis and acute kidney injury among Medicare beneficiaries after hospitalization for heart failure.

Heart Failure 40

Heart Failure Hospital Medicare Outcomes 40

American College of Cardiology

FEBRUARY 19, 2025

Atrial fibrillation catheter ablation (AFCA) improved clinical outcomes compared with medical treatment alone, and early AFCA was associated with better outcomes than late AFCA, particularly decreased risk of heart failure (HF) hospitalization and atrial fibrillation (AFib) recurrence.

AFIB 68

AFIB Ablation Atrial Fibrillation Outcomes 68

European Journal of Heart Failure

FEBRUARY 25, 2025

A post-hoc analysis of the TRANSFORM-HF trial including patients hospitalized for heart failure categorized by discharge dose group of furosemide and torsemide. Study endpoints included all-cause mortality, hospitalization and the composite of all-cause mortality and hospitalization over 12months.

Heart Failure 40

Heart Failure Hospital Outcomes Cardiomyopathy 40

American College of Cardiology

MAY 20, 2024

Are there differences between empagliflozin and dapagliflozin for the composite outcome of all-cause mortality and hospitalization in patients with heart failure (HF)?

Outcomes 67

Outcomes Heart Failure Hospital Article 67

Circulation: Cardiovascular Interventions

MARCH 4, 2024

High-volume MVr centers and high-volume TEER centers have better outcomes than low-volume centers, respectively. However, whether MVr volume predicts TEER outcomes remains unknown. Heart failure readmission at 1 year was 9.4% One-year mortality was 15.0%

Bicuspid/Mitral 72

Bicuspid/Mitral Hospital Outcomes Heart Failure 72

DAIC

JANUARY 29, 2024

Getty Images milla1cf Mon, 01/29/2024 - 14:24 January 29, 2024 — Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under age 65 with severe aortic stenosis , many hospitals are still opting for a nonsurgical approach in patients under 60—possibly with poorer survival rates.

Aortic valve 111

Aortic valve TAVR Aortic Outcomes 111

Becker's Hospital Review - Cardiology

JANUARY 17, 2024

Researchers found no significant difference in patient outcomes or adverse events for acute heart failure patients treated at a short-stay unit instead of being hospitalized.

Heart Failure 59

Heart Failure Hospital Research Outcomes 59

Medical Xpress - Cardiology

MARCH 17, 2025

Heart failure is a major health concern, especially for aging populationsit significantly increases mortality rates, and severely impacts quality of life of those affected. Exercise therapy has been shown to be particularly effective for patients with heart failure.

Heart Failure 40

Heart Failure Exercise Quality of Life Hospital 40

Cardiology Update

DECEMBER 11, 2023

In a recent study published in Circulation: Heart Failure , researchers analyzed a large group of individuals with various cardiopulmonary diseases who had undergone right heart catheterization. year follow-up, those with right ventricular dysfunction faced an increased risk of mortality and heart failure hospitalization.

Obesity 52

Obesity Hospital Outcomes Heart Failure 52

Conquering CHD

JANUARY 17, 2025

Seeing two brothers have HLHS is extremely rare and even more rare is how differently the condition presented in each child, says Childrens Hospital Colorado cardiothoracic surgeon Max Mitchell, MD, who performed the procedures on Zane and advised on Zekes care. We dont put limitations on them unless its for their safety, says Kayla.

Heart Transplant 98

Heart Transplant Transplant Open-Heart Surgery Nursing 98

European Journal of Heart Failure

FEBRUARY 26, 2025

Proposed approach for clinical management and therapeutic optimization in patients with heart failure with reduced ejection fraction and low blood pressure. We propose management pathways to optimize HFrEF treatment in the context of low BP, ultimately aiming to improve patient outcomes.

Blood Pressure 58

Blood Pressure Heart Failure Aortic valve TAVR 58

Frontiers in Cardiovascular Medicine

MARCH 3, 2025

The blood urea nitrogen/creatinine ratio (BCR) has proven more effective at predicting outcomes in heart failure patients than individual assessments of each marker. Nevertheless, the implications of varying BCR levels for outcomes among heart failure patients remain to be fully understood. of the cohort.

Heart Failure 52

Heart Failure Critical Care Hospital Outcomes 52

Circulation: Cardiovascular Quality & Outcomes

JANUARY 27, 2025

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:The absence of practice standards in vasoactive agent usage for acute decompensated heart failure has resulted in significant treatment variability across hospitals, potentially affecting patient outcomes. female), 88.6%

Heart Failure 40

Heart Failure Hospital Pulmonary Laboratory 40

American College of Cardiology

FEBRUARY 1, 2024

What are the characteristics and outcomes of cardiogenic shock (CS) in children hospitalized for acute decompensated heart failure (ADHF)?

Cardiogenic Shock 66

Cardiogenic Shock Outcomes Heart Failure Hospital 66

DAIC

DECEMBER 18, 2024

12, 2024 Physicians have a new treatment option for many of the sickest pediatric patients with heart failure andcardiogenic shock. and Impella CP enable heart recovery as part of the world's smallest heart pump platform. and Impella CP enable heart recovery as part of the world's smallest heart pump platform.

Pediatrics 52

Pediatrics Cardiogenic Shock Heart Failure Quality of Life 52

DAIC

MAY 17, 2024

Based on the Health Data Hub complete medico-administrative database and comprehensive datasets from Implicity's AI -based remote monitoring platform, the Implicity team trained and validated a machine learning algorithm that assesses the risk of future heart failure events, enabling physicians to intervene before a patient requires hospitalization.

Heart Failure 52

Heart Failure Pacemaker Hospital Defibrillator 52

Frontiers in Cardiovascular Medicine

FEBRUARY 7, 2024

Introduction There have been few studies on predictors of weaning failure from MV in patients with heart failure (HF). We sought to investigate the predictive value of B-lines measured by lung ultrasound (LUS) on the risk of weaning failure from mechanical ventilation (MV) and in-hospital outcomes.

Ultrasound 69

Ultrasound Heart Failure Hospital Outcomes 69

Circulation: Cardiovascular Quality & Outcomes

DECEMBER 6, 2023

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Background:Overall outcomes and the escalation rate for home hospital admissions for heart failure (HF) are not known. of hospitalizations. There was no unexpected mortality during home hospitalization. were women, and 64.8% were White.

Heart Failure 40

Heart Failure Hospital Outcomes Inpatient 40

Frontiers in Cardiovascular Medicine

MARCH 12, 2025

ObjectivesTelenursing in cardiac care leverages technology to support self-care and optimize outcomes for heart failure patients during and beyond the pandemic.

Nursing 52

Nursing Education Heart Failure Technology 52

American College of Cardiology

FEBRUARY 6, 2025

History of prior heart failure (HF) was found to influence prognostic implications of atrial fibrillation (AFib) in patients hospitalized for HF, with permutations of prior HF, prior AFib and AFib as presenting rhythm differentiating outcome.

AFIB 56

AFIB Hospital Atrial Fibrillation Heart Failure 56

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Background The obesity occurrence has achieved epidemic levels worldwide and several studies indicate a paradoxical similarity among obesity and the prognosis in heart failure (HF). Methods We analyzed 1,556 medical records from the HF outpatient clinic of a quaternary hospital and 242 were selected according to the criteria.

Outpatient 59

Outpatient Obesity Heart Failure BMI 59

Circulation

NOVEMBER 11, 2024

Adjusted odds ratios (aOR) were calculated for outcomes and Kaplan-Meier survival analysis curves with log-rank tests over five-year follow-up were analyzed using R software.Results:There were 11384 participants matched to each cohort; the average age at diagnosis was 72.5 + 11.6 Patients with rheumatic valve disease were excluded.

Heart Failure 40

Heart Failure Preserved Ejection Fraction Bicuspid/Mitral Outcomes 40